Aaron Luke Silverstein
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aaron Luke Silverstein has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Warren Joseph Alilain
Spinal Cord and Brain Injury Research Center, College of Medicine, University of Kentucky, Lexington, KY 40536-0509, USA
5 shared publications Christopher J. McLouth
Department of Biostatistics, College of Public Health, Biostatistics Consulting and Interdisciplinary Research Collaboration Lab, University of Kentucky, 725 Rose St., Lexington, KY 40536, United States of America
1 shared publicationChristopher M. Calulot
Department of Neuroscience, Spinal Cord and Brain Injury Research Center, College of Medicine, University of Kentucky, 741 S. Limestone St., Lexington, KY 40508, United States of America
1 shared publicationH. Francis Farhadi
Department of Neuroscience, Spinal Cord and Brain Injury Research Center, College of Medicine, University of Kentucky, Lexington, Kentucky, USA
1 shared publicationJohn C. Gensel
Department of Physiology, Spinal Cord and Brain Injury Research Center, College of Medicine, University of Kentucky, 741 S. Limestone St., Lexington, KY 40508, United States of America
1 shared publicationKatelyn G. Lawson
Department of Neuroscience, Spinal Cord and Brain Injury Research Center, College of Medicine, University of Kentucky, Lexington, Kentucky, USA
1 shared publication
Latest Publications
- Open Access
- 21 October 2025
- Published by Elsevier in Experimental Neurology
- Vol. 396, 115522
Liposome-encapsulated clodronate and COX-2 inhibitor treatment impair ventilatory recovery but improve compensatory locomotor function following cervical spinal cord injury in rats
- 21 October 2025
- Published by Elsevier in Experimental Neurology
- Vol. 396, 115522
Open AccessLiposome-encapsulated clodronate and COX-2 inhibitor treatment impair ventilatory recovery but improve compensatory locomotor function following cervical spinal cord injury in rats
- Open Access
- 25 November 2024
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 332, 104373
Ethanol abolishes ventilatory long-term facilitation and blunts the ventilatory response to hypoxia in female rats
- 25 November 2024
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 332, 104373
Open AccessEthanol abolishes ventilatory long-term facilitation and blunts the ventilatory response to hypoxia in female rats
- Open Access
- 30 November 2023
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 40 (23-24) , 2469-2486
Contrasting Experimental Rodent Aftercare With Human Clinical Treatment for Cervical Spinal Cord Injury: Bridging the Translational “Valley of Death”
More than half of all spinal cord injuries (SCIs) occur at the cervical level and often lead to life-threatening breathing motor dysfunction. The C2 hemisection (C2Hx) and high cervical contusion mouse and rat models of SCI are widely utilized both to understand the pathological effects of SCI and to develop potential therapies. Despite rigorous research effort, pre-clinical therapeutics studied in those animal models of SCI sometimes fail when evaluated in the clinical setting. Differences between standard-of-care treatment for acute SCI administered to clinical populations and experimental animal models of SCI could influence the heterogeneity of outcome between pre-clinical and clinical studies. In this review, we have summarized both the standard clinical interventions used to treat patients with cervical SCI and the various veterinary aftercare protocols used to care for rats and mice after experimentally induced C2Hx and high cervical contusion models of SCI. Through this analysis, we have identified areas of marked dissimilarity between clinical and veterinary protocols and suggest the modification of pre-clinical animal care particularly with respect to analgesia, anticoagulative measures, and stress ulcer prophylaxis. In our discussion, we intend to inspire consideration of potential changes to aftercare for animal subjects of experimental SCI that may help to bridge the translational “Valley of Death” and ultimately contribute more effectively to finding treatments capable of restoring independent breathing function to persons with cervical SCI.
- 30 November 2023
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 40 (23-24) , 2469-2486
Open AccessContrasting Experimental Rodent Aftercare With Human Clinical Treatment for Cervical Spinal Cord Injury: Bridging the Translational “Valley of Death”
More than half of all spinal cord injuries (SCIs) occur at the cervical level and often lead to life-threatening breathing motor dysfunction. The C2 hemisection (C2Hx) and high cervical contusion mouse and rat models of SCI are widely utilized both to understand the pathological effects of SCI and to develop potential therapies. Despite rigorous research effort, pre-clinical therapeutics studied in those animal models of SCI sometimes fail when evaluated in the clinical setting. Differences between standard-of-care treatment for acute SCI administered to clinical populations and experimental animal models of SCI could influence the heterogeneity of outcome between pre-clinical and clinical studies. In this review, we have summarized both the standard clinical interventions used to treat patients with cervical SCI and the various veterinary aftercare protocols used to care for rats and mice after experimentally induced C2Hx and high cervical contusion models of SCI. Through this analysis, we have identified areas of marked dissimilarity between clinical and veterinary protocols and suggest the modification of pre-clinical animal care particularly with respect to analgesia, anticoagulative measures, and stress ulcer prophylaxis. In our discussion, we intend to inspire consideration of potential changes to aftercare for animal subjects of experimental SCI that may help to bridge the translational “Valley of Death” and ultimately contribute more effectively to finding treatments capable of restoring independent breathing function to persons with cervical SCI.
- Open Access
- 6 July 2021
- Published by SAGE Publications in Neurotrauma Reports
- Vol. 2 (1) , 343-353
Intermittent Hypoxia Induces Greater Functional Breathing Motor Recovery as a Fixed Rather Than Varied Duration Treatment after Cervical Spinal Cord Injury in Rats
Intermittent hypoxia treatment (IH) has been shown to improve respiratory function in both pre-clinical animal models and human subjects following spinal cord injury (SCI), historically consisting of alternating and equal intervals of hypoxic and normoxic exposure. We describe such a procedure as fixed duration IH (FD-IH) and modulation of its severity, intermittency, and post-injury time-point of application differentially affects expression of breathing motor plasticity. As such, the established IH protocol exhibits similarity to instrumental conditioning and can be described as behavioral training through reinforcement. Findings from the field of operant conditioning, a form of more advanced learning, inspire the consideration that FD-IH protocols may be improved through exchanging fixed for varied durations of hypoxia between reinforcement. Thus, we hypothesized that varied duration intermittent hypoxia treatment (VD-IH) would induce greater breathing motor recovery ipsilateral to injury than FD-IH after cervical SCI in rats. To test this hypothesis, we treated animals with VD-IH or FD-IH for 5 days at 1 week and at 8 weeks following cervical SCI, then assessed breathing motor output by diaphragm electromyography (EMG) recording, and compared between groups. At 1 week post-injury, VD-IH-exposed animals trended slightly toward exhibiting greater levels of respiratory recovery in the hemidiaphragm ipsilateral to lesion than did FD-IH-treated animals, but at 8 weeks FD-IH produced significantly greater respiratory motor output than did VD-IH. Thus, these results identify a novel sensitivity of respiratory motor function to variations in the IH protocol that may lead to development of more effective treatments following SCI.
- 6 July 2021
- Published by SAGE Publications in Neurotrauma Reports
- Vol. 2 (1) , 343-353
Open AccessIntermittent Hypoxia Induces Greater Functional Breathing Motor Recovery as a Fixed Rather Than Varied Duration Treatment after Cervical Spinal Cord Injury in Rats
Intermittent hypoxia treatment (IH) has been shown to improve respiratory function in both pre-clinical animal models and human subjects following spinal cord injury (SCI), historically consisting of alternating and equal intervals of hypoxic and normoxic exposure. We describe such a procedure as fixed duration IH (FD-IH) and modulation of its severity, intermittency, and post-injury time-point of application differentially affects expression of breathing motor plasticity. As such, the established IH protocol exhibits similarity to instrumental conditioning and can be described as behavioral training through reinforcement. Findings from the field of operant conditioning, a form of more advanced learning, inspire the consideration that FD-IH protocols may be improved through exchanging fixed for varied durations of hypoxia between reinforcement. Thus, we hypothesized that varied duration intermittent hypoxia treatment (VD-IH) would induce greater breathing motor recovery ipsilateral to injury than FD-IH after cervical SCI in rats. To test this hypothesis, we treated animals with VD-IH or FD-IH for 5 days at 1 week and at 8 weeks following cervical SCI, then assessed breathing motor output by diaphragm electromyography (EMG) recording, and compared between groups. At 1 week post-injury, VD-IH-exposed animals trended slightly toward exhibiting greater levels of respiratory recovery in the hemidiaphragm ipsilateral to lesion than did FD-IH-treated animals, but at 8 weeks FD-IH produced significantly greater respiratory motor output than did VD-IH. Thus, these results identify a novel sensitivity of respiratory motor function to variations in the IH protocol that may lead to development of more effective treatments following SCI.